Veeva Systems Other Income (Expense) decreased by 0.4% to $71.66M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 26.4%, from $56.71M to $71.66M. Over 4 years (FY 2022 to FY 2026), Other Income (Expense) shows an upward trend with a 150.6% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.56M | $1.67M | $824.00K | $0.00 | $2.71M | $8.40M | $12.46M | $26.44M | $30.25M | $38.83M | $42.19M | $47.43M | $51.73M | $58.57M | $60.94M | $56.71M | $65.09M | $69.46M | $71.93M | $71.66M |
| QoQ Change | — | -63.5% | -50.5% | -100.0% | — | +210.0% | +48.3% | +112.2% | +14.4% | +28.4% | +8.7% | +12.4% | +9.1% | +13.2% | +4.0% | -6.9% | +14.8% | +6.7% | +3.6% | -0.4% |
| YoY Change | — | — | — | — | -40.6% | +404.1% | >999% | — | >999% | +362.3% | +238.6% | +79.4% | +71.0% | +50.9% | +44.4% | +19.6% | +25.8% | +18.6% | +18.0% | +26.4% |
| Segment | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|
| Reportable Segment | $65.09M | $69.46M | $71.93M | $71.66M |
| Total | $65.09M | $69.46M | $71.93M | $71.66M |